Calian Group Ltd. (TSX:CGY)

Intra-Cellular Therapies Ratios and Metrics

Market cap in millions CAD. Fiscal year is October - September.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Market Capitalization	578	543	604	649	688	655
Market Cap Growth	-23.21%	-10.10%	-6.88%	-5.70%	5.04%	136.56%
Enterprise Value	680	630	581	624	650	628
Last Close Price	49.45	45.03	49.02	52.72	56.45	61.05
PE Ratio	11797.64	48.59	32.00	47.70	61.69	32.17
Forward PE	9.79	9.53	13.59	13.91	16.91	23.84
PS Ratio	0.78	0.73	0.92	1.12	1.33	1.52
PB Ratio	1.80	1.66	1.84	2.13	2.35	3.27
P/TBV Ratio	-	-	7.14	7.07	5.30	6.19
P/FCF Ratio	15.21	7.20	12.50	18.03	17.59	-
P/OCF Ratio	12.01	6.23	10.64	15.04	14.78	-
PEG Ratio	-	1.20	1.20	1.20	1.20	1.20
EV/Sales Ratio	0.91	0.84	0.88	1.07	1.25	1.45
EV/EBITDA Ratio	9.74	8.13	9.45	11.18	13.31	18.44
EV/EBIT Ratio	25.37	14.42	15.47	17.95	19.79	24.24
EV/FCF Ratio	17.88	8.36	12.02	17.34	16.62	-
Debt / Equity Ratio	0.51	0.40	0.23	0.09	0.06	0.10
Debt / EBITDA Ratio	2.37	1.55	1.13	0.45	0.34	0.53
Debt / FCF Ratio	4.36	1.71	1.55	0.74	0.45	-
Asset Turnover	0.98	1.15	1.16	1.16	1.31	1.64
Inventory Turnover	19.13	21.81	22.37	32.70	61.62	74.26
Quick Ratio	1.18	1.07	1.15	1.20	2.02	2.05
Current Ratio	1.38	1.29	1.36	1.40	2.16	2.19
Return on Equity (ROE)	0.01%	3.41%	5.96%	4.55%	4.53%	12.91%
Return on Assets (ROA)	2.20%	4.22%	4.15%	4.32%	5.21%	6.15%
Return on Capital (ROIC)	3.60%	6.36%	6.39%	6.78%	7.75%	9.30%
Return on Capital Employed (ROCE)	5.10%	8.90%	9.60%	10.40%	9.80%	10.90%
Earnings Yield	0.01%	2.06%	3.13%	2.10%	1.62%	3.11%
FCF Yield	6.57%	13.88%	8.00%	5.55%	5.69%	-1.12%
Dividend Yield	2.22%	2.49%	2.28%	2.12%	1.98%	1.83%
Payout Ratio	-	119.42%	69.70%	93.83%	106.01%	48.81%
Buyback Yield / Dilution	0.45%	-1.62%	-3.14%	-6.98%	-16.87%	-15.78%
Total Shareholder Return	2.67%	0.87%	-0.85%	-4.86%	-14.89%	-13.95%

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.